SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007096
Filing Date
2019-05-14
Accepted
2019-05-14 16:31:29
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 554189
2 ex31-1.htm EX-31.1 21158
3 ex31-2.htm EX-31.2 21569
4 ex32-1.htm EX-32.1 8604
5 ex32-2.htm EX-32.2 8111
  Complete submission text file 0001493152-19-007096.txt   2983983

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20190331.xml EX-101.INS 470538
7 XBRL SCHEMA FILE prph-20190331.xsd EX-101.SCH 46912
8 XBRL CALCULATION FILE prph-20190331_cal.xml EX-101.CAL 49249
9 XBRL DEFINITION FILE prph-20190331_def.xml EX-101.DEF 120364
10 XBRL LABEL FILE prph-20190331_lab.xml EX-101.LAB 288862
11 XBRL PRESENTATION FILE prph-20190331_pre.xml EX-101.PRE 197949
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 19823207
SIC: 2834 Pharmaceutical Preparations